These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway. Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672 [TBL] [Abstract][Full Text] [Related]
24. Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300. Boissinot M; King H; Adams M; Higgins J; Shaw G; Ward TA; Steele LP; Tams D; Morton R; Polson E; da Silva B; Droop A; Hayes JL; Martin H; Laslo P; Morrison E; Tomlinson DC; Wurdak H; Bond J; Lawler SE; Short SC Oncogene; 2020 Jul; 39(30):5292-5306. PubMed ID: 32555332 [TBL] [Abstract][Full Text] [Related]
25. Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation. Tao Z; Li T; Ma H; Yang Y; Zhang C; Hai L; Liu P; Yuan F; Li J; Yi L; Tong L; Wang Y; Xie Y; Ming H; Yu S; Yang X Cell Death Dis; 2018 Oct; 9(11):1063. PubMed ID: 30337536 [TBL] [Abstract][Full Text] [Related]
26. Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo. Lamour V; Henry A; Kroonen J; Nokin MJ; von Marschall Z; Fisher LW; Chau TL; Chariot A; Sanson M; Delattre JY; Turtoi A; Peulen O; Rogister B; Castronovo V; Bellahcène A Int J Cancer; 2015 Sep; 137(5):1047-57. PubMed ID: 25620078 [TBL] [Abstract][Full Text] [Related]
27. Blockade of the NFκB pathway drives differentiating glioblastoma-initiating cells into senescence both in vitro and in vivo. Nogueira L; Ruiz-Ontañon P; Vazquez-Barquero A; Lafarga M; Berciano MT; Aldaz B; Grande L; Casafont I; Segura V; Robles EF; Suarez D; Garcia LF; Martinez-Climent JA; Fernandez-Luna JL Oncogene; 2011 Aug; 30(32):3537-48. PubMed ID: 21423202 [TBL] [Abstract][Full Text] [Related]
28. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue. Ruiz-Ontañon P; Orgaz JL; Aldaz B; Elosegui-Artola A; Martino J; Berciano MT; Montero JA; Grande L; Nogueira L; Diaz-Moralli S; Esparís-Ogando A; Vazquez-Barquero A; Lafarga M; Pandiella A; Cascante M; Segura V; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL Stem Cells; 2013 Jun; 31(6):1075-85. PubMed ID: 23401361 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6. Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-210 regulates cell proliferation and apoptosis by targeting regulator of differentiation 1 in glioblastoma cells. Zhang S; Lai N; Liao K; Sun J; Lin Y Folia Neuropathol; 2015; 53(3):236-44. PubMed ID: 26443314 [TBL] [Abstract][Full Text] [Related]
32. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy. Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679 [TBL] [Abstract][Full Text] [Related]
33. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. Wang H; Sun T; Hu J; Zhang R; Rao Y; Wang S; Chen R; McLendon RE; Friedman AH; Keir ST; Bigner DD; Li QJ; Wang H; Wang XF J Clin Invest; 2014 Oct; 124(10):4489-502. PubMed ID: 25202981 [TBL] [Abstract][Full Text] [Related]
34. Circular RNA hsa_circ_0076248 promotes oncogenesis of glioma by sponging miR-181a to modulate SIRT1 expression. Lei B; Huang Y; Zhou Z; Zhao Y; Thapa AJ; Li W; Cai W; Deng Y J Cell Biochem; 2019 Apr; 120(4):6698-6708. PubMed ID: 30506951 [TBL] [Abstract][Full Text] [Related]
35. Genome Editing Reveals Glioblastoma Addiction to MicroRNA-10b. El Fatimy R; Subramanian S; Uhlmann EJ; Krichevsky AM Mol Ther; 2017 Feb; 25(2):368-378. PubMed ID: 28153089 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-203 As a Stemness Inhibitor of Glioblastoma Stem Cells. Deng Y; Zhu G; Luo H; Zhao S Mol Cells; 2016 Aug; 39(8):619-24. PubMed ID: 27484906 [TBL] [Abstract][Full Text] [Related]
37. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy. Xu JX; Yang Y; Zhang X; Luan XP Anat Rec (Hoboken); 2021 Feb; 304(2):342-352. PubMed ID: 32275350 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. Lee HK; Bier A; Cazacu S; Finniss S; Xiang C; Twito H; Poisson LM; Mikkelsen T; Slavin S; Jacoby E; Yalon M; Toren A; Rempel SA; Brodie C PLoS One; 2013; 8(2):e54652. PubMed ID: 23390502 [TBL] [Abstract][Full Text] [Related]
39. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids. Doğanlar O; Doğanlar ZB; Delen E; Doğan A Tissue Cell; 2021 Dec; 73():101617. PubMed ID: 34418770 [TBL] [Abstract][Full Text] [Related]
40. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis. Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]